By Ethan Covey
The FDA issued a boxed warning for the diabetes drug canagliflozin because it can increase the risk for leg and foot amputations.
Canagliflozin is marketed by Janssen as Invokana, Invokamet and Invokamet XR.
MAY 23, 2017
MAY 23, 2017